JENNIFER JORDALEN: Open Payments
NPI 1659027753 · BELLINGHAM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 42 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $382 · 2025 $1,198
Food & beverage: $998Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $812 |
| ABBVIE INC. | 8 | $136 |
| Lilly USA, LLC | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| REVANCE THERAPEUTICS, INC. | 1 | $40 |
| UCB, Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Incyte Corporation | 1 | $15 |
Products named: TREMFYA, SKYRIZI, EBGLYSS, COSENTYX, DAXXIFY, BOTOX, Rhapsido, Bimzelx.
Industry payments across WA — which companies pay providers there.
